Skip to main content
Equibles

LPL Financial LLC

Position in EDIT — Editas Medicine, Inc.

CIK 1403438 FORT MILL, SC
Back to EDIT Full portfolio

Position in EDIT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$748,812
+$576,399 QoQ
Shares Held
231,115
+231.1% QoQ
Ownership
0.150%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 216 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in EDIT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. EDIT ranks #76 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 289,111 $143,610,107
2 REGN
Regeneron Pharmaceuticals, Inc.
 65,755 $41,000,872
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 310,761 $25,330,129
4 ARGX
Argenx SE
 19,499 $18,090,587
5 ALNY
Alnylam Pharmaceuticals, Inc.
 57,890 $17,426,626
6 HALO
Halozyme Therapeutics, Inc.
 203,557 $15,932,406
7 RPRX
Royalty Pharma plc
 249,117 $13,967,990
8 INSM
INSMED Inc
 128,553 $13,706,320

All Filings in EDIT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $748,812 231,115
2026-03-31 $172,413 69,803
2025-12-31 $132,954 64,856
2025-09-30 $143,703 41,413
2025-06-30 $96,646 43,930
2025-03-31 $53,923 46,486
2024-12-31 $67,726 53,328
2024-09-30 $223,767 65,621
2024-06-30 $365,754 78,320
2024-03-31 $530,351 71,476
2023-12-31 $776,748 76,678
2023-09-30 $619,881 79,472
2023-06-30 $630,064 76,557
2023-03-31 $452,914 62,471
2022-12-31 $435,082 49,051
2022-09-30 $535,083 43,716
2022-06-30 $529,510 44,760
2022-03-31 $721,409 37,929
2021-12-31 $1,156,836 43,572
2021-09-30 $2,161,958 52,628
2021-06-30 $2,765,957 48,834
2021-03-31 $2,726,430 64,915
2020-12-31 $4,186,268 59,710
2020-09-30 $1,610,812 57,406
2020-06-30 $1,554,783 52,562
2020-03-31 $491,070 24,764